• Uses dielectrophoresis ‘DEP’ to selectively capture and concentrate target particles (such as bacterial cells), based on the physical properties of the target, such as size and composition.
• Can be applied to almost any target type, from macromolecules to circulating tumour cells, effectively removing contaminating cells, debris and inhibitors.
• Preserves cell viability; cells can continue to metabolise and even undergo division while held in the capture fields.

CAPTURE-XT cleans up samples and concentrates target microorganisms for:

• Visual inspection¹.
• Culture.
• Molecular analysis².

Applied to Mycobacterium tuberculosis from sputum samples, CAPTURE-XT can:​

• Capture tubercule bacilli for visual analysis​ as an alternative to sputum smear microscopy.
• Provide a concentrated and purified sample for:
  • Molecular analysis.
  • Culture & drug susceptibility testing.

CAPTURE-XT is applicable to more than just TB. Dielectrophoretic technology can be applied to:

• Other targets such as different microorganisms, viruses, human cells (including circulating tumour cells) or macromolecules.
• Other sample types, including urine and blood.

QuantuMDx intends to develop the CAPTURE-XT platform to be compatible with a broad range of targets and sample matrices.

We want to hear from you!

• If you have a use for CAPTURE-XT in your research.
• If you can help with sample provision for TB applications.
• To explore other uses for this novel technology.